Savara Begins Rolling BLA for Molbreevi for Rare Lung Disease
alveoli © Kenny Parker - stock.adobe.comPharmaceutical company Savara has initiated a rolling biologics license application (BLA) with the FDA for...
alveoli © Kenny Parker - stock.adobe.comPharmaceutical company Savara has initiated a rolling biologics license application (BLA) with the FDA for...
Every time Cherith Satterfield took a deep breath, she would hear a whistle. The 39-year-old thought she was having seasonal...
Wildfire smoke has long been known to exacerbate health problems like heart disease, lung conditions, and asthma, but now a...
electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx,...
<< Back December 04, 2024 When it comes to lung cancer, early detection can be life-saving. But are you not...
Lung cancer is the leading cause of cancer death worldwide, according to the World Health Organization.This is partly because the...
Our lung cancer service had experienced pressure in the past, so the team was redesigned to ensure that patients receive...
Winrevair, which treats hypertension from constricted lung arteries, costs $3,700-$6,730The National University Heart Centre, Singapore (NUHCS) will start using sotatercept (Winrevair)...